As of 2020, the global probiotics market size was estimated at $54.77 billion and these figures are only expected to grow at a compound annual growth rate (CAGR) of 7.2 percent from 2021 to 2028. Driven by the growing consumer inclination towards preventive healthcare in conjunction with the development of efficient probiotic strains, the probiotic adoption is also influenced by Increased awareness about Nutrition, Increased Accessibility to Nutritional Supplements, Adoption of various strategies to lower the dependency on China for Probiotics, and Extensive research in this field. These probiotics when consumed in adequate amounts have desirable effects on the body, primarily - improved gut health and reduced intestinal inflammation. Probiotics have been playing a great role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Thus, rising awareness regarding preventive healthcare is expected to boost the market growth over the forecast period.
An industry veteran with years of experience, Pruthivin Reddy was quick enough to Recognize the opportunities in the Preventive healthcare industry. Cashing on these Favourable chances, in 2018, Pruthivin Reddy established Elmed Life Sciences, an ISO 9001:2015 certified and US FDA registered company that specializes in the manufacturing of Probiotics and Nutraceuticals, with products available in dosage forms such as liquids, powders, capsules, tablets, and syrups. Headquartered in Hyderabad, Telangana, Elmed Life Sciences has a WHO-GMP certified manufacturing facility with a combined 20k square feet of space allotted for R&D, Quality Control, Quality Assurance, and Packaging.
A Promise to Ensure Quality Lifestyle for all
With the probiotic domain growing rapidly, they are being used in foods, dietary supplements, and drugs for the well-being of people ranging from health-conscious to those that need treatment for disease conditions. Probiotics today have come a long way from being considered as an ‘adjuvant’ to an independent therapy, with proven efficacies in treating difficult to treat chronic conditions. ELMED Life Sciences is thriving to address some of these health conditions through the use of Probiotics.
With most customer demands based on the quality and price of the products, ELMED Life Sciences is committed to delivering solutions at an affordable price without compromising on quality. "At ELMED Life Sciences, we believe in keeping the quality unhindered as per our motto, priority, and a common ingredient of all our products. We have been developing many innovative products in the probiotic space. Adding to this, we are also the first company in the world to offer Saccharomyces boulardii & Lactobacillus rhamnosus in the form of a stable emulsion”, speaks Pruthivin Reddy, Founder & Managing Director, ELMED Life Sciences.
Keeping up with its mission to serve its global customers, Elmed Life Sciences is striving to design and develop products in conformance with the landmark guidelines outlined by The United Nations Food and Agriculture organization (FAO) and World health organization in Codex Alimentarius for safety and applicability of nutraceuticals. Since these guidelines are adopted by regulatory agencies like US-FDA, European Food safety authority and FSSAI, India, this ensures that Elmed’s products conform to expectations and requirements of all applicable standards.
Taking note of this, the firm has also designed an end-to-end blueprint for the lifecycle management of the products. “We have deployed a robust Quality Management system involving the principles of PDCA (Plan Do Check Act) cycle which drives our product development and realization process. At Elmed, we are equipped with advanced automated manufacturing equipment for manufacturing a comprehensive range of nutraceutical dosage forms including Tablets, Capsules, Drops, Syrups, Oral Suspensions, Emulsions, Sachets and gummies,” adds Pruthivin.
Leveraging Technology to Deliver Quality at all Times
Elmed Life Sciences firmly believe that Quality has to be built into the product by design. Hence, the products developed in the R&D follow the Quality by Design (QBD) approach in line with ICH -Q8 (International Conference on Harmonization). Owing to Technology transfer from R&D, process validation and stability, studies of the product are carried out as per ICH guidelines. “Critical to the quality of our products is our State-of-the-art manufacturing facility which enables a Complete closed-loop manufacturing process with automated control and monitoring systems. Standard operating and testing procedures are established governing all aspects of manufacturing in line with current Good Manufacturing Practices (cGMP). Every batch at Elmed Life Sciences undergoes 100 percent visual inspection by experienced visual inspectors prior to release. A multistep check, review and oversight by Quality Assurance and Quality Control personnel ensures and assures SISPQ (Safety, Identity, Strength, Purity and Quality) of our products,” elaborates Pruthivin.
Nikhil Konkathi, Co-Founder & Director
With its well-established R&D and Business Development functions, Elmed Life Sciences has also stepped up to take part in Contract Manufacturing and Research Services to co-develop products that can cater to the global market. Pruthivin says, “As much as we have grown as a brand, we endeavor to establish a robust community, ready to own their health and necessities. Our customer-centric philosophy ultimately strives to meet the demands of our consumers by making healthcare more accessible. Our innovation and commitment to create value for our customers will be proactive by continuously improving our products. We maintain transparency and integrity in the relations with all business associates”.
Keeping up with the advancements in the industry and the constant tech developments, Elmed Life Sciences has deployed non-thermal processing steps wherever required to offset the loss of bioactive compounds during such thermal processing. The firm also brings to use some of the latest techniques like ultra-filtration, Tangential filtration, Lyophilization, gamma radiation which are involved in the process as a necessity to reduce the processing times, control Maillard reactions, improve products’ quality and enhance functionality. Given the fact that the understanding of Nutraceutical is at a nascent stage in the general population, Elmed Life Sciences continues to embrace digital tools & technologies to disseminate knowledge at the forefront.
At ELMED Life Sciences, we believe in keeping the quality unhindered as per our motto, priority, and a common ingredient of all our products
Setting New Benchmarks to Follow on
Elmed’s Journey has had its own ups and downs with lessons on perseverance, grit, and a relentless that drive to change the world of probiotics through science and innovation. The firm’s first innovation in the probiotics space was formulating the Emulsion form of Saccharomyces boulardii and Lactobacillus rhamnosus with the use of a novel technology that enabled the Probiotics to be stable and withstand room temperatures. Having started with 7-10 people, today Elmed Life Sciences has a team of 150+ people. “At Elmed, we strongly believe in Phil Jackson’s quote - ‘The strength of the team is each individual member. The strength of each member is the team’. Our production team is highly qualified with team members having vast experience in the field of Probiotics manufacturing. Our sales & marketing team comes with immense exposure to the domestic and international probiotic markets. Adding to this, we have strong partners and clients in South East Asia, Latin America, Middle East, and CIS countries. We are still thriving to expand our reach to various untapped markets,” shares Pruthivin.
At present, Elmed Life Sciences is cherishing its leadership position in providing contract manufacturing services for Probiotic products which fall under key therapeutic segments like Gut Health. The firm also holds a significant position and has an active presence in gynaecology and paediatrics domain. “We strongly believe that our gut is the second brain. At Elmed Life Sciences, our team is committed to creating awareness and formulating innovative products keeping in mind the association between gut health and mental health and the role ‘Psycobiotics’ have to play in the management of general anxiety, mood swings, irritability, and depression. Our R&D team is also working on innovative probiotics solutions for the management of Diabetes, Bacterial Vaginosis, and Cancer-related symptoms. Consumers are increasingly looking for healthy foods that provide probiotic benefits because of which the functional food market is evolving. We at Elmed are thriving to develop Probiotic infused functional foods and beverages that are designed for the generally healthy population that, however, regularly experiences episodes of 'suboptimal' health,” signs-off Pruthivin.